Cargando…

Quantification and expert evaluation of evidence for chemopredictive biomarkers to personalize cancer treatment

Predictive biomarkers have the potential to facilitate cancer precision medicine by guiding the optimal choice of therapies for patients. However, clinicians are faced with an enormous volume of often-contradictory evidence regarding the therapeutic context of chemopredictive biomarkers. We extensiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rao, Shruti, Beckman, Robert A., Riazi, Shahla, Yabar, Cinthya S., Boca, Simina M., Marshall, John L., Pishvaian, Michael J., Brody, Jonathan R., Madhavan, Subha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514962/ https://www.ncbi.nlm.nih.gov/pubmed/27888622 http://dx.doi.org/10.18632/oncotarget.13544

Ejemplares similares

Evidence-Based Network Approach to Recommending Targeted Cancer Therapies
por: Kancherla, Jayaram, et al.
Publicado: (2020)

Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients
por: Howard, Candace M., et al.
Publicado: (2017)

Identification of Prognostic and Chemopredictive microRNAs for Non-Small-Cell Lung Cancer by Integrating SEER-Medicare Data
por: Ye, Qing, et al.
Publicado: (2021)

A case for expert curation: an overview of cancer curation in the Clinical Genome Resource (ClinGen)
por: Ritter, Deborah I., et al.
Publicado: (2019)

A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution’s experience
por: Lowder, Cinthya Y., et al.
Publicado: (2020)

Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study
por: Boca, Simina M., et al.
Publicado: (2016)

Real-world Studies Link NSAID Use to Improved Overall Lung Cancer Survival
por: Roszik, Jason, et al.
Publicado: (2022)

Correction: Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study
por: Boca, Simina M., et al.
Publicado: (2016)

A virtual molecular tumor board to improve efficiency and scalability of delivering precision oncology to physicians and their patients
por: Pishvaian, Michael J, et al.
Publicado: (2019)

Pharmacogenomic characterization of gemcitabine response – a framework for data integration to enable personalized medicine
por: Harris, Michael, et al.
Publicado: (2014)

Collaborative, Multidisciplinary Evaluation of Cancer Variants Through Virtual Molecular Tumor Boards Informs Local Clinical Practices
por: Rao, Shruti, et al.
Publicado: (2020)

viGEN: An Open Source Pipeline for the Detection and Quantification of Viral RNA in Human Tumors
por: Bhuvaneshwar, Krithika, et al.
Publicado: (2018)

SNP2Structure: A Public and Versatile Resource for Mapping and Three-Dimensional Modeling of Missense SNPs on Human Protein Structures
por: Wang, Difei, et al.
Publicado: (2015)

EGR1 regulates cellular metabolism and survival in endocrine resistant breast cancer
por: Shajahan-Haq, Ayesha N., et al.
Publicado: (2017)

A direct approach to estimating false discovery rates conditional on covariates
por: Boca, Simina M., et al.
Publicado: (2018)

Enhancing the REMBRANDT MRI collection with expert segmentation labels and quantitative radiomic features
por: Sayah, Anousheh, et al.
Publicado: (2022)

Author Correction: Enhancing the REMBRANDT MRI collection with expert segmentation labels and quantitative radiomic features
por: Sayah, Anousheh, et al.
Publicado: (2022)

eGARD: Extracting associations between genomic anomalies and drug responses from text
por: Mahmood, A. S. M. Ashique, et al.
Publicado: (2017)

Understanding bias when estimating life expectancy from age at death: a simulation approach applied to Morquio syndrome A
por: Yin, Xue, et al.
Publicado: (2022)

A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative
por: Pishvaian, Michael J., et al.
Publicado: (2016)

Adapting crowdsourced clinical cancer curation in CIViC to the ClinGen minimum variant level data community‐driven standards
por: Danos, Arpad M., et al.
Publicado: (2018)

Multi-omic molecular comparison of primary versus metastatic pancreatic tumours
por: Brar, Gagandeep, et al.
Publicado: (2019)

An Expert System for Quantification of Bradykinesia Based on Wearable Inertial Sensors
por: Bobić, Vladislava, et al.
Publicado: (2019)

WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner
por: Lal, Shruti, et al.
Publicado: (2016)

In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases
por: McGarvey, Peter B, et al.
Publicado: (2014)

Discovery of potential urine-accessible metabolite biomarkers associated with muscle disease and corticosteroid response in the mdx mouse model for Duchenne
por: Thangarajh, Mathula, et al.
Publicado: (2019)

Differentially expressed miRNAs in triple negative breast cancer between African-American and non-Hispanic white women
por: Sugita, Bruna, et al.
Publicado: (2016)

Helping experts and expert teams perform under duress: an agenda for cognitive aid research
por: Marshall, S. D.
Publicado: (2016)

Expert Systems and Robotics
por: Isenhour, T. L., et al.
Publicado: (1988)

Standardizing And Democratizing Access To Cancer Molecular Diagnostic Test Data From Patients To Drive Translational Research
por: Madhavan, Subha, et al.
Publicado: (2018)

iTextMine: integrated text-mining system for large-scale knowledge extraction from the literature
por: Ren, Jia, et al.
Publicado: (2018)

Expert Evidence
Publicado: (1899)

Personalizing guidelines for diabetes management: twilight or dawn of the expert?
por: Paschou, Stavroula A, et al.
Publicado: (2013)

Integrated copy number and miRNA expression analysis in triple negative breast cancer of Latin American patients
por: Sugita, Bruna M., et al.
Publicado: (2019)

A Computational Approach for Prioritizing Selection of Therapies Targeting Drug Resistant Variation in Anaplastic Lymphoma Kinase
por: McCoy, Matthew D., et al.
Publicado: (2018)

Patient-oriented gene set analysis for cancer mutation data
por: Boca, Simina M, et al.
Publicado: (2010)

Limitations of Expert Evidence
por: James, D S
Publicado: (1995)

Limitations of Expert Evidence
por: Badenoch Qc, James
Publicado: (1996)

On Column Binding a Real-Time Biosensor for β-lactam Antibiotics Quantification
por: Abdullah, Shahla M., et al.
Publicado: (2020)

16 expert lessons for successfully managing your personal finances
por: FTPress Delivers
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_723q2t27ri1kvjakg5hjlobcp4